Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00314964|
Recruitment Status : Completed
First Posted : April 17, 2006
Last Update Posted : March 16, 2011
|Condition or disease||Intervention/treatment||Phase|
|Hot Flashes||Drug: PD-0299685||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||527 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study Evaluating PD-0299685 for Treatment of Vasomotor Symptoms Associated With Menopause|
|Study Start Date :||August 2006|
|Actual Study Completion Date :||July 2007|
- Effectiveness of PD-0299685 in reducing both the frequency and severity of vasomotor symptoms, from baseline to week 4 and week 12.
- To assess the safety profile of PD-0299685; the benefit of PD-0299685 in quality of life measures and treatment satisfaction of PD-0299685, when compared with placebo.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00314964
Show 80 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|